Tackling The Global Threat Of Antimicrobial Resistance
La Trobe University scientists have identified a key bacterial function that may lead to new treatments for drug-resistant infections, a major global health threat that killed 1.14 million people in 2021. The university has launched the REACH initiative to tackle antimicrobial resistance by bringing together scientists, clinicians, and the community.
La Trobe University has launched a major research initiative to combat antimicrobial resistance (AMR), a growing global problem that killed 1.14 million people in 2021. The Research and Engagement for Antimicrobial Resistance and Community Health (REACH) initiative brings together scientists, clinicians, and the community to find new ways to prevent and treat drug-resistant infections. Researchers at La Trobe's Institute for Molecular Science have identified a key bacterial function that could lead to new treatments. The team, led by Professor Begoña Heras, discovered the precise regions of a protein responsible for its activity, providing a foundation for future drug development. REACH will draw on the expertise of La Trobe scientists to tackle AMR. By 2050, up to 8.22 million people are expected to die annually from AMR-associated infections if new treatments are not developed.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.